Govt rejects SII plea to export 50 lakh doses of Covishield to UK
Despite the international pressure and several rounds of negotiations by Serum Institute of India (SII), the government has turned down the request from SII to export 50 lakh doses of Covishield to UK under its prior commitments. The decision was taken in the wake of severe supply crunch of vaccines locally and government insisting the local production be supplied to protect Indians first.
💡 newsR Knowledge: Other News Mentions
'We were struggling': Govt criticised over 'lack of support' for children with special needsThe government is being urged to bring forward its review into support for children with special educational needs and disabilities after claims that a lack of..
Campaigners welcome Government apology over 'failing' rape victims
Credit: PA - Press Association STUDIO Duration: 01:06Published
Tamil Nadu: NGO report claims Covid-19 deaths likely eight times more, Govt denies| Oneindia News
Credit: Oneindia Duration: 02:58Published
Minister on travel: 'Govt is thinking about all aspects'
Credit: ODN Duration: 01:04Published
Serum Institute's COVID-19 vaccine 'Covovax' likely to launch by SeptemberThe new vaccine shall be launched under the brand name of Covovax, which SII is manufacturing in partnership with US pharmaceutical firm Novovax.
SII, Bharat Biotech seek hike in government price for Covid vaccinesSerum Institute of India (SII) and Bharat Biotech (BB) are seeking higher prices for Covid-19 vaccines from the Centre amid concerns that the cost of Covishield..
COVID-19: Serum Institute's Novavax vaccine shows 90% overall efficacyNovavax in collaboration with Indian drug manufacturer Serum Institute of India is manufacturing these vaccines for India and low-income countries.
Covid-19: Novavax set for India launch with Serum Institute of India as manufacturing partnerThe uncertain path to authorisation in the US for Novavax despite passing the efficacy test with an impressive score of 90.4% might see India emerge as a major..
Novavax vaccine over 90% effective in U.S. trial
Credit: Reuters - Politics Duration: 01:41Published
PM Modi says focus must be on repairing and preparing the health infrastructure| Oneindia News
Credit: Oneindia Duration: 02:36Published
Covishield dose gap: Dr Harsh Vardhan says decision based on scientific data | Oneindia News
Credit: Oneindia Duration: 02:06Published
Covid-19: Decision to extend gap between doses was unanimous, says govtThe decision to increase the gap between two doses of Covishield vaccine from 4-6 weeks to 12-16 weeks was “unanimous” and based on studies that showed that..
No quarantine for Covishield vaccinated Indians in South Korea, mandatory for Covaxin recipients: Envoy
German envoy extends support to India amid COVID crisis
Credit: ANI Duration: 01:44Published
You Might Like
Related videos from verified sources
Related news from verified sources